Newly released data from Express Scripts shows that the number of prescriptions filled per week for antidepressants, anti-anxiety and anti-insomnia medications combined jumped 21% between mid-February and mid-March — reaching a zenith during the week ending March 15, when the COVID-19 outbreak officially reached pandemic status. And analytics from UnitedHealth Group’s OptumRx showed prescription increases of 15% for anti-anxiety medications, 14% for antidepressants and 5% for anti-insomnia medications during the month of March. In the first three weeks of April, prescriptions for such medications started declining, “but still remain higher than average prescription fills,” according to an OptumRx spokesperson.
- Datapoint, Medicare and Medicaid
- Abstract, Health Plans
- People on the Move
- Medicare and Medicaid
- Datapoint, Drug Benefits